Comparative trial of extra-amniotic and vaginal prostaglandin E2 in tylose gel for induction of labor by Clarke, G. A. et al.
236 Clarke et aL, Prostaglandin for induction of labor
Original articles
J. Perinat Med.
8(1980)236
Comparative trial of extra-amniotic and vaginal prostaglandin E2 in
tylose gel for induction of labor
G. A. Clarke*, A. T. Letchworth**, A. D. Noble***
* Registrar, Dept. of Obstetrics and Gynaecology, Royal Hampshire County
Hospital, Winchester
** Senior Lecturer, Dept. of Human Reproduction and Obstetrics, Southhampton
University and Honorary Consultant, Dept. of Obstetrics and Gynaecology,
Royal Hampshire County Hospital, Winchester
*** Consultant, Dept. of Obstetrics and Gynaecology, Royal Hampshire County
Hospital, Winchester
l Introduction
Oral, intravenous and local prostaglandins have
now been widely studied for the induction of
labor. Significant benefits have been demonstra-
ted for the induction of abortion and the induc-
tion of labor when the cervix is unfavourable
[12, 14].
When the cervix is favourable, prostaglandins alone
have not been shown to have significant advant-
ages over surgical induction and Syntocinon and
are associated with a high incidence of gastro-
intestinal side effects [6,15],
However, surgical induction is not without pro-
blems. When the cervix is unripe, artifical rupture
of the membranes (ARM) may be difficult and
labor may be long or fail to become established.
It is also associated with the risk of umbilical
cord prolapse and uterine infection. There is a
growing reluctance by patients to undergo surgical
induction with its discomfort, frequent require-
ment for intravenous infusion and subsequent
confinement to bed. There is also an increased
workload on nursing staff.
Local protaglandins (vaginal and extra-amniotic)
have been used with success for pre-induction
'priming' when the cervix is unripe and have been
found to produce less gastrointestinal side effects
than other routes of administration [3,11, 13].
This trial sets out to compare the effectiveness of
single doses of PGE2 in tylose gel given either
extraamniotically or vaginally prior to the surgical
induction of labor in patients of varying parity
and cervical 'ripeness'.
2 Method
Patients under two of the consültants at the Royal
Hampshire County Hospital who required induc-
tion were included in the trial, unless there was
clinical or biochemical evidence of placental in^
sufficiency, suspected cephalo-pelvic dispropor-
tion, a scarred Uterus, or a malpresentation.
Prostaglandin E2 (PCE2-Upjohn) in 10ml of
6 per cent tylose gel (Beseht) was used. The
vaginal dose given was 2.0 mgm and the extra-
amniotic dose given was 0.3 mgm.
Patients for induction of labor were randomly
assigned to either group according to whether
their date of birth was in an odd or even year.
At midday on the day prior to planned surgical
induction, the prostaglandins were inserted via a
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assessment of the cervix for 'ripeness' using a
modified BISHOP's score [1]. The catheter was
then withdrawn. According to the route desig-
nated, the PGE2 was placed either into the post-
erior fornix of the vagina, or extra-amniotically
posterior to the presenting part, just inside the in-
ternal os. No cervical stretching or sweeping of
fetal membranes was carried out. The patients
were rested in bed for two hours and then allowed
to ambulate. If labor became established, artificial
rupture of the membranes was only performed
when the cervix was at least 5 cm dilated. Fetal
heart monitoring was performed when possible.
The patients who were not delivered or in esta-
blished labor within 20 hours were reassessed and
artificial rupture of the membranes performed.
Intravenous Syntocinon was then used in these
patients when indicated.
3 Results
A total of 261 patients were studied, of whom
128 were given vaginal PGE2, and 133 were given
extra-amniotic PGE2. There was no statistically
significant difference in the two groups in respect
of age, gestation, parity and cervical 'ripeness'.
The indications for induction were varied but
4post-maturity' and pre-eclampsia were the most
common indications. The induction of labor was
considered successful if the patients were delivered
vaginally within 24 hours of the application of the
prostaglandins without further Stimulation other
than ARM in labor (Tab. I). The results were
further subdivided according to parity and
BISHOP's score (Tab. I).
Five patients became established in labor with
PGE2 with cervical dilatation greater than 5 cm,
but then developed secondary inertia. They re-
quired intravenous Syntocinon and were not
included in the successful induction group.
No Caesarean sections were required in the group
who became established in labor following
prostaglandin induction. The induction-delivery
intervals in the successful groups were similar
(Tab. II).
Hypertonus for the purposes of this trial was
defined äs failure of the uterus to relax between
contractions, or contractions lasting longer than
Tab. I. Relationship of cervical score and parity to inci-
dence of laboi after PGE2 alone.
Vaginal
Number of
patients
Number who
Modified
BISHOP
Score
<5
(less than)
PG MG
32 27
11 11
Modified
BISHOP
Score
> 5
(greater
than)
PG MG
29 40
11 34
AU
patients
128
67
labored following
PGE2 alone
Percentage who
labored following
PGE2 alone
Extra-amniotic
Number of
patients
Number who
labored following
PGE2 alone
Percentage who
labored following
PGE2 alone
Significance of
difference (x2)
34.4 40.7 37.9 85.0 52.3
34 33
11 12
35 31 133
13 17 53
32.4 36.4 37.1 54.8 39.8
NS NS NS p<.01 NS
PG = Primigravid
MG = Multigravid
NS = Not significant
Tab. II. Results when labor followed administration of
PGE2 alone.
Mean induc-
tion delivery
interval
(hours ± SD)
Mean 1 minute
APGAR
score ± SD
Vaginal
PGE2
9.9 ± 5.4
8.2 ±1.1
Extra-
Arn niotic
PGE2
10.9 ± 5.4
8.4 ± 1.1
Significance
of difference
NS
(student)
NS
two minutes. There were no cases of hypertonus
during this trial. There were eight patients in the
vaginal group who had labors lasting less than
four hours. All were multigravida with 'ripe' cer-
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vices. Two patients (one multigravida and one
primigravida) in the extra-amniotic group also
had labors of less than four hours. There were
no apparent ill effects to mother or fetus from
these labors.
Apart from one patient who had been suffering
from diarrhoea and vomiting for two days prior
induction, no patients developed diarrhoea fol-
lowing the use of prostaglandins, and there were
no cases of vomiting prior to sedation being given
in labor.
Of the patients who labored successfully foll-
owing prostaglandin treatment, there was only one
infant with an Apgar score of less than 5 at l
minute and the APGAR scores in this case were 4
and 9 at l and 5 minutes respectively. The mean
Apgar scores for the two grpups of successful
inductions showed no significant difference (Tab.
H).
No significant fetal heart abnormalities were
noted during the first stage of labor in either
group when labor was successfully induced
with prostaglandins. Four of the patients were
delivered by forceps for suspected fetal distress
in the second stage of labor, but all these infants
had good APGAR scores at birth.
Only one patient out of the 261 studied developed
an intra-partum pyrexia. This patient failed to
establish in labor following vaginal prostaglandins
and then required Caesarean section for failure to
progress in labor 24 hours after sürgical induc-
tion.
There was a moderate improvement in BISHOP'S
score for the two groups of patients requiring sür-
gical induction (Tab. III). The mean induction
Tab. III. Results when sürgical induction was required.
Vaginal PGE2 Extra-Amniotic
PGE2
Mean change 2.1 ± 1.5
in modified
BISHOP
score ± SD
MG
2.1 ± 1.5
PG MGMean induction PG
tion delivery
interval 10.0 ± 5.4 7.1 ± 3.2 11.1 ± 5.6 6.7 ±3.1
(hours ± SD)
delivery intervals for these patients (excluding
Caesarean sections) were similar in both groups
(Tab. III). Eight patienis required Caesarean
section for suspected cephalo-pelvic dispropor-
tion and failure to progress in labor after sürgical
induction.
4 Discussion
Both routes of administration achieved significant
reductions in the requirement for the sürgical in-
duction of labor. In the dosages used, the vaginal
route established labor in a higher proportion of
patients, but this was not statistically significant,
except in the group of multigravida with 4ripe'
cervices. In both schedules patients who were
multiparous or had a high BISHOP'S score were
more likely to establish in labor with prostaglan-
dins. This is in agreement with previous studies
with local prostaglandins [2, 7].
Despite the wide Variation in parity and cervical
score, both schedules were found to be without
significant risk to the mother of the fetus. Al-
though not all patients could be monitored
throughout labor, patients were monitored when
indicated. The absence of any detected significant
fetal heart abnormalities and the good APGAR
scores of all infants at 5 minutes is reassuring.
Gastro-intestinal side effects have been frequent
with many prostaglandin regimes [4, 8,10], but in
the dosages used in this trial these did not occur.
Recent work has demonstrated the value of
ambulant labor [5]. The use of local prostaglan-
dins extends the advantages of this type of labor
to a greater proportion of induced labors.
In the group of patients who were not success-
fully established in labor with the use of pro-
staglandins, there was a moderate improvement
in the BISHOP'S score, which was compatable for
both routes of administration. The mean induc-
tion-delivery intervals for these self-selected labor
resistänt groups were acceptable although no
direct comparison could be made with nion-primed
labors. Previous trials have shown the benefits of
cervical priming with extra-amniotic and vaginal
prostaglandins followed by sürgical induction,
with respect to length of labor, success or surgical
induction, and maternal and fetal well-being {2,
J. Perinat. Med. 8 (1980)
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7, 9]. A relatively small percentage of primiparous
patients and those with unripe cervices became
established in labor. As more experience is gained,
a variable dose of prostaglandins could be given,
being calculated according to parity and BISHOP's
score.
Patient response is difficult to assess objectively
but it has been feit that the simplicity of the in-
duction procedure and the ability to ambulate in
early labor has led to an improved acceptance by
patients of induction of labor.
Although both routes of administration achieved
similar results, vaginal prostaglandins have the ad-
vantage of simplified applications, ease of removal
if required and the avoidance of the potential risks
of trans-cervical invasion of the Uterus [8]. The
availability of vaginal pessaries would further
simplify the administration of the prostaglandins.
Summary
Two hundred and sixty-one patients of varying parity and
cervical ttpeness" were given Prostaglandin E2 (PCE2> in
tylose gel either vaginally (2.0 mgm) or extraamniotically
(0.3 mgm) prior to planned surgical induction.
Surgical inductions was avoided in 52 per cent of the
vaginal group and 40 per cent of the extra-amniotic
group. When subdivided according to parity and cervical
Keywords: Parity, prostaglandines, ripeness.
ripeness, both groups were comparable except in die
multigravid patients with high cervical 'scores', when the
vaginal route was significantly more likely to estabiish
labor.
Both groups were without significant ül-effects to the
mother or fetus.
Zusammenfassung
Vergleichende Untersuchung über extraamniale und vagi-
nale Prostaglandin E2-Applikation zur Weheninduktion
261 Patientinnen unterschiedlicher Parität und mit ver-
schiedenen zervikalen Reifebefunden erhielten einen Pro-
staglandin E2-Tylose-Gel (PGE2>, der kurz vor einer ge-
planten „operativen'4 Einleitung entweder vaginal (2.0mg)
oder extraamnial (0.3 mg) appliziert wurde.
Die „operative" Einleitung konnte in der vaginalen
Gruppe bei 52%, in der extraamnialen Gruppe bei 40%
Schlüsselwörter: Parität, Prostaglandine, Reifestatus.
umgangen werden. Unterteilt man die Gruppen nach
Parität und zervikalem Reifestatus, so haben beide Appli-
kationsformen bis auf die Gruppe der Mehrgebärenden
vergleichbare Erfolgsquoten. Bei Mehrgebärenden mit
einem reifen Zervixbefund scheint die vaginale Anwen-
dung die Wehentätigkeit besser zu stimulieren.
Es wurden in beiden Gruppen weder bei der Mutter noch
beim Kind Nebenwirkungen beobachtet.
Resume
Essai comparatif d'application extraamniotique et vagi-
nale de prostaglandine E2 sous forme de gel de tylose
pour induction du travail.
De la prostaglandine E2 (PGE2) a ete appliquee a deux
cent soixante et une patientes ayant des parites et matu-
rites cervicales diverses,, soit par voie vaginale (2,0 mgm),
soit par voie extraamniotique, avant d'entreprendre Fin-
duction instrumentale.
Mots-cles: Maturite, parite, prostaglandine.
L'induction instrumentale a ete necessaire dans 52% des
cas du groupe «vaginal» et dans 40% des cas du groupe
«extra-amniotique». En tenant compte des parites et
maturites cervicales, les deux groupes etaient comparables,
a Fexception des multipares a haut score cervical, oü la
voie vaginale etait significativement plus apte ä induire le
travail.
Les deux groupes etaient sans differences significatives
pour ce qui est de la morbidite maternelle ou foetale.
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